Autologous Mesenchymal Stem Cells Transplantation in Thoracolumbar Chronic and Complete Spinal Cord Injury Spinal Cord Injury

Summary

The purpose of this study is to analyze the safety and efficacy of autologous bone marrow mesenchymal stem cell transplantation in patients with thoracolumbar chronic and complete spinal cord injury.

Conditions

• Spinal Cord Injury

Interventions

BIOLOGICAL

Autologous mesenchymal cells transplantation

Two percutaneous injections of mesenchymal stem cells, with a 3-month interval between the injections.

Sponsors & Collaborators

• Hospital Sao Rafael

  lead OTHER

Principal Investigators

• Ricardo Ribeiro-dos-Santos, PhD · Hospital São Rafael

• Milena BP Soares, PhD · Hospital São Rafael

• Bruno SF Souza, MD, Msc · Hospital São Rafael

• Ticiana F Larocca, MD, Msc · Hospital São Rafael

• Rodrigo L Alves, MD, PhD · Hospital São Rafael

• Carolina T Macedo, MD, MSc · Hospital São Rafael

• André C Matos, MD · Hospital São Rafael

• Cristiane F Villarreal, PhD · Hospital São Rafael

• Antônio Olímpio S Moura, MD · Hospital São Rafael

• Eduardo Brazão, MD · Hospital São Rafael

• Kátia N Silva, MSc · Hospital São Rafael

• Daniela N Silva, MSc · Hospital São Rafael

• Clarissa LM de Souza, MD · Hospital São Rafael

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

65 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2019-12-31

Primary Completion

2021-12-31

Completion

2022-01-31